Development of a normal tissue complication probability model for late unfavourable aesthetic outcome after breast-conserving therapy

References

• Ferlay J, Soerjomataram I, Ervik M. et al. GLOBOCAN 2012 v1.1, Cancer Incidence and [Online] Lyon, France: International Agency for Research on Cancer; 2014. [cited 2017 Oct 9]. Available from: http://globocan.iarc.fr
   Google Scholar
• Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–1241.
   PubMed Web of Science ®Google Scholar
• Litière S, Werutsky G, Fentiman IS, et al. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol. 2012;13:412–419.
   PubMed Web of Science ®Google Scholar
• Darby S, McGale P, Correa C, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378:1707–1716.
   PubMed Web of Science ®Google Scholar
• Taylor C, Correa C, Duane FK, et al. Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials. J Clin Oncol. 2017;35:1641–1649.
   PubMed Web of Science ®Google Scholar
• Waljee J, Hu E, Ubel P, et al. Effect of esthetic outcome after breast-conserving surgery on psychosocial functioning and quality of life. J Clin Oncol. 2008;26:3331–3337.
   PubMed Web of Science ®Google Scholar
• Cardoso M, Cardoso J, Vrieling C, et al. Recommendations for the aesthetic evaluation of breast cancer conservative treatment. Breast Cancer Res Treat. 2012;135:629–637.
   PubMed Web of Science ®Google Scholar
• Cardoso J, Cardoso M. Towards an intelligent medical system for the aesthetic evaluation of breast cancer conservative treatment. Artif Intell Med. 2007;40:115–126.
   PubMed Web of Science ®Google Scholar
• Harris J, Levene M, Svensson G, et al. Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. Int J Radiat Oncol Biol Phys. 1979;5:257–261.
   PubMed Web of Science ®Google Scholar
• Hennigs A, Hartmann B, Rauch G, et al. Long-term objective esthetic outcome after breast-conserving therapy. Breast Cancer Res Treat. 2015;153:345–351.
   PubMed Web of Science ®Google Scholar
• Collins G, Reitsma J, Altman D, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Br J Cancer. 2015;112:251–259.
   PubMed Web of Science ®Google Scholar
• Verhoeven K, Kindts I, Laenen A, et al. A comparison of three different radiotherapy boost techniques after breast conserving therapy for breast cancer. Breast. 2015;24:391–396.
   PubMed Web of Science ®Google Scholar
• Taylor ME, Perez CA, Halverson KJ, et al. Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys. 1995;31:753–764.
   PubMed Web of Science ®Google Scholar
• Poortmans P, Bartelink H, Horiot J, et al. The influence of the boost technique on local control in breast conserving treatment in the EORTC ‘boost versus no boost’ randomised trial. Radiother Oncol. 2004;72:25–33.
   PubMed Web of Science ®Google Scholar
• Hammer C, Maduro J, Bantema-Joppe E, et al. Radiation-induced fibrosis in the boost area after three-dimensional conformal radiotherapy with a simultaneous integrated boost technique for early-stage breast cancer: a multivariable prediction model. Radiother Oncol. 2017;122:45–49.
   PubMed Web of Science ®Google Scholar
• Cardoso M, Cardoso J, Santos A, et al. Factors determining esthetic outcome after breast cancer conservative treatment. Breast J. 2007;13:140–146.
   PubMed Web of Science ®Google Scholar
• Offersen BV, Boersma LJ, Kirkhove C, et al. ESTRO consensus guidelines on target volume delineation for elective radiation therapy of early stage breast cancer. Radiother Oncol. 2015;114:3–10.
   PubMed Web of Science ®Google Scholar
• Bentzen S, Agrawal R, Aird E, et al. The UK standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol. 2008;9:331–341.
   PubMed Web of Science ®Google Scholar
• Niemierko A. Reporting and analyzing dose distributions: a concept of equivalent uniform dose. Med Phys. 1997;24:103–110.
   PubMed Web of Science ®Google Scholar
• American Association of Physicists in Medicine. Report of AAPM task group 166 of the therapy physics committee. The use and QA of biologically related models for treatment planning. March 2012.
   Google Scholar
• Tucker S, Liu H, Liao Z, et al. Analysis of radiation pneumonitis risk using a generalized Lyman model. Int J Radiat Oncol Biol Phys. 2008;72:568–574.
   PubMed Web of Science ®Google Scholar
• Kutcher G, Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. Int J Radiat Oncol Biol Phys. 1989;16:1623–1630.
   PubMed Web of Science ®Google Scholar
• Lyman J. Complication probability as assessed from dose-volume histograms. Radiat Res Suppl. 1985;8:S13–S19.
   PubMedGoogle Scholar
• Hanley J, McNeil B. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29–36.
   PubMed Web of Science ®Google Scholar
• Hosmer D, Lemeshow S. Applied Logistic regression. New York: John Wiley & Sons Inc. 1989.
   Google Scholar
• Van Limbergen E, Rijnders A, van der Schueren E, et al. Cosmetic evaluation of breast conserving treatment for mammary cancer. 2. A quantitative analysis of the influence of radiation dose, fractionation schedules and surgical treatment techniques on cosmetic results. Radiother Oncol. 1989;16:253–267.
   PubMed Web of Science ®Google Scholar
• Senkus E, Kyriakides S, Ohno S, on behalf of the ESMO Guidelines Committee, et al. Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl5):v8–30.
   Google Scholar
• Van der Laan H, Dolsma W, Maduro J, et al. Three-dimensional conformal simultaneously integrated boost technique for breast-conserving radiotherapy. Int J Radiat Oncol Biol Phys. 2007;68:1018–1023.
   PubMed Web of Science ®Google Scholar
• Hurkmans C, Meijer G, van Vliet-Vroegindeweij C, et al. High-dose simultaneously integrated breast boost using intensity-modulated radiotherapy and inverse optimization. Int J Radiat Oncol Biol Phys. 2006;66:923–930.
   PubMed Web of Science ®Google Scholar
• Vrieling C, Collette L, Fourquet A, et al. The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. Radiother Oncol. 2000;55:219–232.
   PubMed Web of Science ®Google Scholar
• Van Limbergen E, van der Schueren E, Van Tongelen K. Cosmetic evaluation of breast conserving treatment for mammary cancer. 1. Proposal of a quantitative scoring system. Radiother Oncol. 1989;16:159–167.
   PubMed Web of Science ®Google Scholar
• Mukesh M, Harris E, Collette S, et al. Normal tissue complication probability (NTCP) parameters for breast fibrosis: pooled results from two randomised trials. Radiother Oncol. 2013;108:293–298.
   PubMed Web of Science ®Google Scholar
• Avanzo M, Stancanello J, Trovò M, et al. Complication probabililty model for subcutaneous fibrosis based on published data of partial and whole breast irradiation. Phys Med. 2012;28:296–306.
   PubMed Web of Science ®Google Scholar
• Alexander MA, Brooks WA, Blake SW. Normal tissue complication probability modelling of tissue fibrosis following breast radiotherapy. Phys Med Biol. 2007;52:1831–1843.
   PubMed Web of Science ®Google Scholar
• Pastore F, Conson M, D’Avino V, et al. Dose-surface analysis for prediction of severe acute radio-induced skin toxicity in breast cancer patients. Acta Oncol. 2016;55:466–473.
   PubMed Web of Science ®Google Scholar
• Wuu C, Kliauga P, Zaider M, Amols H. Microdosimetric evaluation of relative biological effectiveness for 103Pd, 125I, 241Am, and 192Ir brachytherapy sources. Int J Radiat Oncol Biol Phys. 1996;36:689–697.
   PubMed Web of Science ®Google Scholar
• Wang J, Huang Z, Lo S, et al. A generalized linear-quadratic model for radiosurgery, stereotactic body radiation therapy, and high-dose rate brachytherapy. Sci Transl Med. 2010;2:39ra48.
   PubMed Web of Science ®Google Scholar
• Bentzen S, Overgaard M. Relationship between early and late normal-tissue injury after postmastectomy radiotherapy. Radiother Oncol. 1991;20:159–165.
   PubMed Web of Science ®Google Scholar
• Marks L, Bentzen S, Deasy J, et al. Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl): S70–S76.
   Web of Science ®Google Scholar